Table 2 Utilization of Medications after PCI
No improvement | Improvement | ||
|---|---|---|---|
(n = 18) | (n = 24) | P value | |
Aspirin | 18 (100%) | 23 (96%) | 0.88 |
Clopidogrel | 17 (94%) | 22 (92%) | 0.79 |
Nitrates | 1 (6%) | - | 0.88 |
PRN NTG | 12 (67%) | 11 (46%) | 0.30 |
Coumadin | 3 (17%) | 5 (21%) | 0.95 |
Beta-blocker | 16 (89%) | 24 (100%) | 0.34 |
ACE inhibitor or ARB | 16 (89%) | 19 (80%) | 0.67 |
Statins | 17 (94%) | 21 (88%) | 0.81 |
Number of patients requiring changes in drug dosage at follow up | |||
Beta-blocker | 5 (28%) | 9 (47%) | 0.74 |
ACE inhibitor or ARB | 5 (28%) | 8 (33%) | 0.96 |
Statins | 3 (17%) | 6 (25%) | 0.78 |